080720 — Union Korea Pharm Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩35bn
- KR₩68bn
- KR₩63bn
- 17
- 50
- 28
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,498 | 1,898 | 20,745 | 6,142 | 6,690 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 34,683 | 27,085 | 26,796 | 33,725 | 34,278 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 52,340 | 44,045 | 58,782 | 54,570 | 49,683 |
Net Property, Plant And Equipment | 33,414 | 39,996 | 43,787 | 44,613 | 34,596 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 96,428 | 97,183 | 119,044 | 112,523 | 94,425 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 28,343 | 23,026 | 44,477 | 58,992 | 59,009 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 38,379 | 28,814 | 66,703 | 63,910 | 64,101 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Total Equity | 58,048 | 68,369 | 52,341 | 48,612 | 30,324 |
Total Liabilities & Shareholders' Equity | 96,428 | 97,183 | 119,044 | 112,523 | 94,425 |
Total Common Shares Outstanding |